Dr. Simone Badal is Senior Lecturer in the Department of Basic Medical Sciences at The University of the West Indies, Mona Campus, Jamaica, and Principal Investigator of the AntiCancer Research Jamaica Laboratory. She has established herself as the Caribbean's leading cancer researcher, developing the first Caribbean-derived cancer cell lines from Black patients—ACRJ-PC28 (prostate) and ACRJ-BC24 (breast cancer series)—revealing ancestry-specific drug responses that challenge decades of assumptions about universal therapeutic efficacy. She has secured over $1 million in competitive funding from NIH, Pfizer, and the Chan Zuckerberg Initiative. Her pioneering work has been recognized with the 2025 Anthony N. Sabga Caribbean Award for Excellence in Science & Technology, selection as a 2024-2025 Springer Nature/BCRF Rising Scholar, the 2022 Flair Distinguished Award for Science & Technology, and designation as a research pioneer by Jamaica's Scientific Research Council. Beyond research, she teaches cell culture at UWI, founded the ACRJ Foundation supporting Caribbean youth education, and serves on Wellcome Trust's Expert Advisory Group for Inclusive Research Design. Her career demonstrates that transformative science addressing global health disparities can emerge from anywhere when given partnership, resources, and commitment.